Literature DB >> 30348691

Banana Flower Extract Suppresses Benign Prostatic Hyperplasia by Regulating the Inflammatory Response and Inducing G1 Cell-cycle Arrest.

Liang-Chih Liu1,2, Yung-Hsiang Lin3, Ying-Chao Lin4,5,6, Chi-Tang Ho7, Chao-Ming Hung8,9, Tzong-DER Way10, DA-Tian Bau11,12.   

Abstract

BACKGROUND/AIM: The banana flower is used for ameliorating urinary disturbance. However, there is limited evidence to support the efficacy or mechanism of action of banana flower against benign prostatic hyperplasia (BPH). In the present study, the anti-BPH activity and mechanisms of banana flower extracts were investigated in vitro and in vivo.
MATERIALS AND METHODS: The banana flower extract is a water-soluble extract obtained by sonication. MTT assay was used to examine whether banana flower extract exhibited cytotoxic effects on BPH-1 cells. The effect of banana flower extract on cell-cycle distribution was examined by flow cytometry. The expression of cell-cycle-regulatory molecules was determined by western blot analysis. Testosterone propionate (TP)-induced rat model of BPH was used to evaluate the anti-BPH activity of banana flower extract in vivo.
RESULTS: Banana flower extract reduced epithelial cell line BPH-1 cell viability through cell-cycle arrest at G1 phase. Moreover, banana flower extract reduced the expression of cyclin D1 and cyclin-dependent kinase 6, while it increased the expression of p53 and p27. Interestingly, banana flower extract suppressed BPH-related inflammatory responses through suppressing cyclo-oxygenase-2 expression and prostaglandin E2 production. Finally, banana flower extract administered orally to male rats reduced prostatic weight and serum dihydrotestosterone level, and improved prostate gland morphology. High-performance liquid chromatography revealed that banana flower extract contains citric acid, taurine, pantothenic acid and nicotinic acid components. In summary, banana flower extract may be used as a therapeutic agent for BPH via anti-proliferative and anti-inflammatory activities. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Banana flower extract; Benign prostatic hyperplasia; G0/G1 arrest; cyclooxygenase-2; prostaglandin E2

Mesh:

Substances:

Year:  2018        PMID: 30348691      PMCID: PMC6365740          DOI: 10.21873/invivo.11389

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  24 in total

Review 1.  Protection by pantothenic acid against apoptosis and cell damage by oxygen free radicals--the role of glutathione.

Authors:  Lech Wojtczak; Vyacheslav S Slyshenkov
Journal:  Biofactors       Date:  2003       Impact factor: 6.113

2.  Pathophysiology of benign prostatic hyperplasia in the aging male population.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2005

3.  Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.

Authors:  D Giri; M Ittmann
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 4.  5alpha-reductase activity in the prostate.

Authors:  W D Steers
Journal:  Urology       Date:  2001-12       Impact factor: 2.649

5.  Differential expression of interleukin-15, a pro-inflammatory cytokine and T-cell growth factor, and its receptor in human prostate.

Authors:  A Handisurya; G E Steiner; U Stix; R C Ecker; S Pfaffeneder-Mantai; D Langer; G Kramer; N Memaran-Dadgar; M Marberger
Journal:  Prostate       Date:  2001-12-01       Impact factor: 4.104

6.  Finasteride targets prostate vascularity by inducing apoptosis and inhibiting cell adhesion of benign and malignant prostate cells.

Authors:  M Tandy Sutton; Melissa Yingling; Ash Vyas; Humphrey Atiemo; Andrew Borkowski; Stephen C Jacobs; Natasha Kyprianou
Journal:  Prostate       Date:  2006-08-01       Impact factor: 4.104

7.  Pantothenic acid and pantothenol increase biosynthesis of glutathione by boosting cell energetics.

Authors:  Vyacheslav S Slyshenkov; Dorota Dymkowska; Lech Wojtczak
Journal:  FEBS Lett       Date:  2004-07-02       Impact factor: 4.124

8.  The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.

Authors:  Giuseppe Penna; Benedetta Fibbi; Susana Amuchastegui; Elisa Corsiero; Gilles Laverny; Enrico Silvestrini; Aravinda Chavalmane; Annamaria Morelli; Erica Sarchielli; Gabriella Barbara Vannelli; Mauro Gacci; Enrico Colli; Mario Maggi; Luciano Adorini
Journal:  Prostate       Date:  2009-04-01       Impact factor: 4.104

9.  Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer.

Authors:  Jens Ekkehard König; Theodor Senge; Ernst Peter Allhoff; Wolfgang König
Journal:  Prostate       Date:  2004-02-01       Impact factor: 4.104

10.  Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis.

Authors:  Grégoire Robert; Aurélien Descazeaud; Nathalie Nicolaïew; Stéphane Terry; Nanor Sirab; Francis Vacherot; Pascale Maillé; Yves Allory; Alexandre de la Taille
Journal:  Prostate       Date:  2009-12-01       Impact factor: 4.104

View more
  1 in total

1.  Cancer Preventive and Therapeutic Potential of Banana and Its Bioactive Constituents: A Systematic, Comprehensive, and Mechanistic Review.

Authors:  Arijit Mondal; Sabyasachi Banerjee; Sankhadip Bose; Partha Pratim Das; Elise N Sandberg; Atanas G Atanasov; Anupam Bishayee
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.